Business Context and Reporting Period
This Form 6-K filing by Solowin Holdings, Ltd. covers the month of December 2025. The report details a corporate action regarding equity compensation rather than financial performance results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a specific equity grant event.
Material Changes and Equity Grant Details
- Grant Date: December 17, 2025.
- Instrument: 578,900 options to purchase Class A ordinary shares.
- Exercise Price: US$4.00 per share.
- Recipients: Certain directors, executive officers, and employees under the Amended and Restated 2023 Equity Incentive Plan.
- Specific Allocation: 60,000 options were granted to Lili Liu, Chief Financial Officer.
- Vesting Schedule: Equal quarterly installments beginning March 1, 2026, with the final vesting date on December 1, 2028.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on future performance, risks, contingencies, or unusual items. The document is limited to the disclosure of the option grant and its incorporation by reference into registration statements on Form S-8 and Form F-3.
Investor Verification Checklist
- Verify the current market price of Class A ordinary shares relative to the US$4.00 exercise price.
- Confirm the total outstanding share count to assess potential dilution from the 578,900 new options.
- Review the full terms of the Amended and Restated 2023 Equity Incentive Plan for performance conditions not detailed in this summary.
- Check subsequent filings for any modifications to the vesting schedule or exercise price.